Your HDL Is Low. Here's the Biological Reason.

CETP, the cholesteryl ester transfer protein, is your body’s HDL traffic manager. Its job is to transfer cholesterol from HDL particles to other lipoproteins (LDL and VLDL) so they can deliver cholesterol where needed. Under normal conditions, CETP activity is carefully balanced: enough activity to move cholesterol around, but not so much that you lose HDL particles faster than you can make them.

The CETP TaqIB and I405V variants slow CETP activity, which sounds protective at first glance. Approximately 40% of people carry at least one copy of these variants. The paradox: slower CETP can raise HDL levels, but it also leaves more cholesterol trapped in HDL particles and less available for delivery to cells that need it. You get a higher HDL number on your bloodwork, but the cholesterol transport machinery becomes less efficient overall. Your liver still has to work harder to manage lipid metabolism.

If you carry a CETP variant, your HDL may be naturally higher than the population average, yet you might still feel like something is off: fatigue after meals, difficulty losing weight, or a sense that despite better HDL numbers, your cardiovascular risk hasn’t budged. That’s because your particle composition has shifted. The cholesterol isn’t moving through your bloodstream as efficiently as it should.

APOE is one of the most powerful genes in cardiovascular biology. It codes for apolipoprotein E, the protein that attaches to HDL, LDL, and VLDL particles so your cells can recognize and absorb them. APOE comes in three main forms: e2, e3, and e4. Most of the population carries e3, which is metabolically neutral. The e2 variant favors HDL; the e4 variant shifts metabolism toward LDL and cardiovascular risk.

The APOE e4 allele, carried by approximately 25% of people with European ancestry, reduces your body’s ability to clear LDL from your bloodstream and often suppresses HDL production. Even at the same dietary intake, people with the e4 variant tend to have lower HDL and higher LDL than e3 or e2 carriers. This effect is especially pronounced when you eat saturated fat or refined carbohydrates. Your liver is genetically less efficient at cholesterol clearance.

If you carry APOE e4, you’ve likely noticed that your cholesterol numbers don’t improve as much as friends’ do when you cut back on unhealthy foods. You may also feel more sensitive to dietary cholesterol: a high-fat meal makes you feel sluggish or bloated. Your body is signaling that it’s struggling to process lipids at the rate you’re consuming them. Your cells are also less efficient at absorbing cholesterol, so your body compensates by producing more, pushing HDL down further.

LDLR codes for the LDL receptor, the protein that sits on your liver cells and physically pulls LDL particles out of your bloodstream. Your body produces these receptors continuously; they grab circulating cholesterol particles and bring them inside the cell where they can be recycled or stored. If you have healthy LDLR function, your liver can clear cholesterol rapidly. If your LDLR is impaired, cholesterol accumulates in your blood and HDL remains low because there’s a backup in the system.

Pathogenic LDLR variants cause familial hypercholesterolemia, a genetic condition affecting 1 in 300 people. But you don’t need a rare mutation to have LDLR function problems. Common genetic variation in LDLR efficiency affects how well your liver clears lipoproteins overall. If your LDLR function is even 20-30% below average, your body cannot clear cholesterol efficiently enough to raise HDL to healthy levels no matter how hard you exercise. Your cells simply cannot receive the lipid clearance signal quickly enough.

If you carry an LDLR variant, you’ve probably experienced this: your total cholesterol and LDL are persistently high or high-normal, while HDL lags. You may have tried statins and found they work partially but never get you to optimal HDL levels. Your liver is genetically less able to pull cholesterol out of your blood, creating a chronic lipid backup that suppresses HDL production.

APOB is the structural protein that sits on the outside of LDL particles. It’s the handle by which your liver’s LDL receptors grab and pull LDL out of your blood. If APOB is defective, even if you have plenty of LDL receptors (LDLR), the particles cannot bind and get cleared. It’s like having a parking lot with open spaces but cars missing license plates; they can’t be identified and parked.

The APOB R3527Q variant and similar loss-of-function mutations, present in approximately 5% of familial hypercholesterolemia cases, prevent LDL particles from binding properly to receptors. People with APOB variants often have strikingly high LDL despite healthy eating and exercise, because their liver receptors are reaching out for particles that cannot respond to the signal. HDL remains low because the cholesterol clearance system is jammed upstream.

If you carry an APOB variant, you experience this as a frustrating disconnect: you do everything right, yet your cholesterol numbers refuse to budge. Your liver is literally unable to recognize and clear your LDL particles. Your blood becomes a backed-up highway of cholesterol that cannot exit. This backup suppresses HDL production because your body senses a cholesterol overload and shuts down the reverse transport system.

PCSK9 is a protein that degrades LDL receptors. Your body recycles these receptors constantly; PCSK9 is the demolition crew that breaks down old receptors so new ones can be made. Under normal conditions, this recycling is balanced. But if you carry a gain-of-function PCSK9 variant, your cells destroy receptors faster than they rebuild them. The result: fewer LDL receptors on your liver cells, less LDL being cleared from your blood, and lower HDL.

Gain-of-function PCSK9 variants occur in approximately 1-3% of the population and markedly elevate LDL cholesterol. Even with a perfectly healthy diet and exercise regimen, gain-of-function PCSK9 variants can raise LDL by 50-100 mg/dL and suppress HDL by 10-20% because your liver simply cannot display enough receptors to manage the cholesterol load. Your body is continuously destroying the very machinery it needs to clear lipids.

If you carry a PCSK9 gain-of-function variant, you’ve likely experienced this as frustrating medication resistance: standard doses of statins (which work by upregulating PCSK9 and increasing receptor production) don’t help as much as they should because your PCSK9 is overactive and destroying the new receptors faster than they can do their job. Your HDL stays low because your liver is unable to achieve efficient cholesterol clearance.

Lipoprotein(a), or Lp(a), is a particle that resembles LDL but carries an additional protein called apolipoprotein(a). Unlike LDL or HDL, Lp(a) levels are almost entirely genetically determined. Your LPA gene controls how much of this particle your liver produces, and diet and exercise have minimal effect on Lp(a) levels. Approximately 20% of the population carries genetic variants that produce elevated Lp(a).

High Lp(a) is a strong independent cardiovascular risk factor, as potent as high LDL or high blood pressure. When Lp(a) is elevated, it circulates in your blood alongside HDL particles, competing for the same metabolic pathways and reducing the effective amount of protective cholesterol transport happening in your bloodstream. You might have an HDL number that looks acceptable on paper, but if your Lp(a) is high, your actual cardiovascular protection is substantially lower.

If you carry a high-Lp(a) genetic variant, you feel this as a sense that something is off with your cardiovascular health even though your doctor keeps saying your numbers are okay. You may have low-grade chest discomfort, unusual fatigue, or a family history of early heart disease that doesn’t match your current lipid profile. Your genes are producing extra Lp(a) particles that are actively increasing your clot risk and oxidative stress, invisible to standard cholesterol panels.